Management of nephrotic syndrome in children

Clinical Immunotherapeutics

Volumn 5, Issue 3, 1996, Pages 175-192

  Brodehl, Johannes ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CHLORMETHINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEFLAZACORT; IMMUNOSUPPRESSIVE AGENT; LEVAMISOLE; PREDNISOLONE; PREDNISONE;

CHILD; CLINICAL TRIAL; FOCAL GLOMERULOSCLEROSIS; HUMAN; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

EID: 0029927652     PISSN: 11727039     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03259081     Document Type: Review

References (99)

1. International Study of Kidney Disease in Children. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 1974; I?-. 159-05
2. GlassockRJ.Cohen AH. BennettCM.et al. Primary glomerular diseases. In: Brenner DG. Rector PC. editors. The kidney. Philadelphia: WB Saunders. 1981: 1351-492
3. Schnaper HW. The immune system in minimal change nephrotic syndrome. Pediatr Nep'hrol 1989: 3: 101-It)
4. Taube D. Williams DG. Pathogèness of minimal change neph ropalhy. In: Cameron JS. Glassock RJ. editors. The ncphrolic syndrome. NeYork: Marcel Dekker. 1988: 193-218
5. Lagueruela CC. Buettner TL. Cole B R. et al. HLA extended haplotypes in steroid-sensitive nephrotic syndrome of cliildhood. Kidney Int 1990: 38: 145-50
6. n. Schnaper HW. A regulatory system for soluble immune response suppressor production in steroid-responsive nephrotic syndrome. Kidney Int 1990: 38: 151-9
7. Levin M. Gascoine P. Turner MW, et al. A highly cationic protein in plasma and urine of children with steroid responsive nephrotic syndrome. Kidney Int 1989; 36: 867-77
8. Arbus GS. Pouccll S. Bacheyie GS. et al. Focal-segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response. J Pediatr 1982: 101: 40-5
9. Anders D. for the Arbeitsgemeinschaft für Pädiatrischc Néphrologie. Cooperative long term follow-up study of children with memhranoproliferative glomerulonephritis (MPGN. 3 types). In: Murakami K. Kkigawa T. Yahuta K. et al., editors. Recent advances in pédiatrie nephrology. Amsterdam: Elsevier Science Publishers. 1987: 253-9
10. Williams DG. Mesangiocapillary glomerulonephritis. In: Cam eron S. Davison AM. Grunfeld J P. et al., editors. Oxford textbook of clinical nephrology. Oxford: Oxford Uni\ersit\ Press. 1992: 388-404
11. Levy M. Infection related proteinuric syndromes. In: Cameron JS. Glassock RJ. editors. The nephrotic syndrome. Neu York : Marcel Dekker. 1988: 745-804
12. Kirn Y. Michael AF. Tarshish P. Infection and nephritis. In: Edelmann CM. editor. Pédiatrie kidney disease. 2nd ed. Buston: Little. Brow n and Co., 1992: 1569-84
13. Fillasire J-P. Druet P. Mery J-P. Proteinuric ncphropathies associated with drugs and substances of abuse. In: Cameron JS.
14. Glassock RJ, editors. The nephrotic syndrome. New York: Marcel Dekker, 1988: 697-744
15. Davison AM, Thomson D. Malignancy-associated glomerular disease. In: Cameron S, Davison AM, Grunfeld J-P, et al., editors. Oxford textbook of clinical nephrology. Oxford: Oxford University Press, 1992: 475-86
16. International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. Identification of patients with minimal-change nephrotic syndrome from initial response to prednisone. J Pediatr 1981; 98: 765-71
17. Brodehl J. Conventional therapy for idiopathic nephrotic syndrome in children. Clin Nephrol 1991; 35 Suppl. 1: S8-SI5
18. Balsan S, Steru D, Bourdeau A, etal. Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth. Calcif Tissue Int 1987:40: 303-9
19. Ferraris JR, Fainstein Day P, Gutman P, et al. EffecI of therapy with a new glucocorticoid, deflazacort, on linear growth and growth hormone secretion after renal transplantation. J Pediatr 1992; 121:809-18
20. Arbeitsgemeinschaft für Pädiatrische Néphrologie. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Lancet 1988; i: 380-3
21. Ehrich JHH, Brodehl J, Arbeitsgemeinschaft für Pädiatrische Néphrologie. Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. EurJ Pediatr 1993; 152:357-61
22. Hoyer PF, Arbeitsgemeinschaft für Pädiatrische Néphrologie. The initial treatment of idiopathic nephrotic syndrome with prednisone and cyclosporin A: preliminary results of a therapeutic trial [abstract]. Pediatr Nephroi 1995; 9: C109
23. Nash MA, Edelmann CM, Berstein J, et al. Minimal change nephrotic syndrome, diffuse mesangial hypercellularity, and focal glomerular sclerosis. In: Edelmann CM, editor. Pédiatrie kidney disease. 2nd ed. Boston: Little, Brown and Co., 1992: 1267-90
24. Arbeitsgemeinschaft für Pädialrische Néphrologie. Alternateday versus intermittent prednisone in frequently relapsing nephrotic syndrome. Lancet 1979; i: 401-3
25. Ueda N, Chihara M, Kawagushi S, et al. Intermittent versus long-term prednisone for initial therapy in children with idiopathic nephrotic syndrome. J Pediatr 1988; 112: 122-6
26. Ksiazek J, Wyszynska T. Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children. Acta Paediatr 1995; 84: 889-93
27. Tsao YC, Yeung CH. Paired trial of cyclophosphamide and prednisone in children with nephrosis. Arch Dis Child 1971; 46:327-31
28. MacDonald NE, Wolfish N, McLaine P, et al. Role of respiratory viruses in exacerbations of primary nephrotic syndrome. J Pediatr 1986; 108:378-82
29. International Study of Kidney Disease in Children. Prospective controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Lancet 1974; ii: 423-7
30. International Study of Kidney Disease in Children. Nephrotic syndrome in children. Randomized trial comparing 2 prednisone regimens in steroid-responsive patients who relapse early. J Pediatr 1979; 95: 239-43
31. Arbeitsgemeinschaft für Pädiatrische Néphrologie. Alternateday prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome. Eur J Pediatr 1981; 135: 229-37
32. Brodehl J. Nephrotic syndrome in children: diagnosis and treatment. World Pediatr Child Care 1986; 1: 9-18
33. Brodehl J. Steroide oder Zytostatika beim kindlichen nephrotischen Syndrom [in German]. Klin Padiatr 1972; 184: 241-9
34. Schoeneman MJ. Minimal change nephrotic syndrome: treatment with low doses of hydrocortisone. J Pediatr 1983; 102: 791-3
35. Srivastava RN, Vasudev AS, Bagga A, et al. Long-term, lowdose prednisolone therapy in frequently relapsing nephrotic syndrome. Pediatr Nephrol 1992; 6: 247-50
36. West CD. Use of combined hormone and mechlorethamine (nitrogen mustard) therapy in lipoid nephrosis. Am J Dis Child 1958:95:498-515
37. Etteldorf JN, Roy S, Summitt RL, et al. Cyclophosphamide in the treatment of idiopathic lipoid nephrosis. J Pediatr 1967; 70: 758-66
38. Chiu J, McLaine PN, Drummond KM. A controlled prospective study of Cyclophosphamide in relapsing, corticosteroidresponsive, minimal-lesion nephrotic syndrome in childhood. J Pediatr 1973:82:607-13
39. Baluarte HJ, Hiner L, Gruskin AB. Chlorambucil dosage in frequently relapsing nephrotic syndrome: a controlled clinical tria!. J Pediatr 1978; 92: 295-8
40. Etteldorf, West CD, Pitcock JA, et al. Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome. J Pediatr 1976; 88: 2206-12
41. Guesry P, Lenoir G, Broyer M. Gonadal effects of chlorambucil given to prepubertal boys for nephrotic syndrome. J Pediatr 1978; 92: 299-303
42. Palmer RG, Dore CJ, Denman AM. Chlorambucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative. Lancet 1984; i: 246-9
43. Kinlen U, Sheil AGR, Peto J, et al. Collaborative United-KingdomAustralian study of cancer in patients treated with immunosuppressive drugs. BMJ 1979; II: 1461-6
44. Al-Khader AA, Lien JWK, Aber GM. Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis. Clin Nephrol 1979; II: 26-30
45. Arbeitsgemeinschaft für Pädiatrische Néphrologie. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med 1982; 306:451-4
46. Arbeitsgemeinschaft für Pädiatrische Néphrologie. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight weeks with 12 weeks course. Arch Dis Child 1987; 62: 1102-6
47. Krohn HP, Brodehl J. Cytotoxic drug study of the APN: 5 year follow up. Helv Paediatr Acta 1986; 41: 107
48. Brodehl J, Hoyer PF. Cyclosporin A treatment of idiopathic nephrotic syndrome in children (minimal change disease and focal segmentai glomerulosclerosis) In: Schindler R, editor. Ciclosporin in autoimmune diseases. Berlin: Springer Verlag, 1985: 329-33
49. Hoyer PF, Krull F, Brodehl J. Cyclosporin in frequently relapsing minimal change nephrotic syndrome. Lancet 1986; i: 335
50. Borel JF. The cyclosporins. Transplant Proc 1989; 21:810-5
51. Kahan BD. Cyclosporin. N Engl J Med 1989; 321: 1725-38
52. Brodehl J, Brandis M, Helmchen U, et al. Cyclosporine A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Klin Wochenschr 1988; 66: 1126-37
53. Capodicasa G, DeSanto NG, Nuzzi F, et al. Cyclosporin A in nephrotic syndrome of childhood - a 14 month experience. Int J Pediatr Nephrol 1986; 7: 69-72
54. Niaudet P, Habib R. Tete MJ, et al. Cyclosporin in the treatment of idioputhic nephrotic syndrome in children. PediatrNephrol 1987; 1:566-73
55. Tejani A, Butt K, Trachtman H, et al. Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int 1988; 33: 729-34
56. Hoyer PF. Brodehl J, Ehrich JHH, et al. Practical aspects in the use of Cyclosporin in paediatric nephrology. Pediatr Nephrol 1991:5:630-8
57. Bökenkamp A. Offner G, Hoyer PF, et al. Improved absorption of cyclosporin A from a new microemulsion formulation: implications for dosage and monitoring. Pediatr Nephrol 1995; 9: 196-8
58. Hulton S-A. Neuhaus TJ, Dillon MJ, et al. Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood. Pediatr Nephrol 1994; 8401-3
59. Niaudet P. French Society of Paediatric Nephrology. Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Pediatr Nephrol 1992; 6: 1-3
60. Ponticelli C, Edefonti A, Ohio L. et al. Cyclosporin \ersus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant 1993:8: 1326-32
61. Collaborative Study Group of Sandimmunf?) in Nephrotic Syndrome. Safety and tolerability of cyclosporin A (Sandimmun-4) in idiopathic nephrotic syndrome. Clin Nephrol 1991;35Suppl. I: S48-60
62. Habib R, Niaudet P. Comparison between pre- and posttreatment renal biopsies in children receiving ciclosporine for idiopathic nephrosis. Clin Nephrol 1994; 42: 141-6
63. Abramowicz M. Arneil GC, Barnett H, et al. Controlled trial of azathioprine in children with nephrotic syndrome. Lancet 1976; i: 959-61
64. Cade R. Mars D. Privette M. et al. Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to cortlcosteroids. Arch Intern Med 1986; 146: 737-41
65. Tanphaichitr P. Tanphaichitr D, Sureeratanan B. et al. Treatment of nephrotic syndrome with levamisole. J Pediatr 1980: 96: 490-3
66. British Association for Paediatric Nephrology. Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. Lancet 1991; 337: 1555-7
67. Workshop by the British Association for Paediatric Nephrology and Research Unit Royal College of Physicians. Consensus statement on management and audit potential for steroid responsive nephrotic syndrome. Arch Dis Child 1994; 70: 151-7
68. Dayal U, Dayal AK. Shastry JCM. et al. Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children. Nephron 1994:66:408-12
69. Symoens J. Veys E. Mielants M. et al. Adverse reactions to levamisole. Cancer Treat Rep 1978; 62: 1721-30
70. International Study of Kidney Disease in Children. Primary nephrotic syndrome in children: clinical significance of histopathological variants of minimal-change and of diffuse inesangial hypercellularity. Kidney Int 1981; 20: 765-71
71. Imbasciatti E, Gusmano R. Edefonti A. et al. Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal chanae nephrotic syndrome. BMJ 1985; 291: 1305-8
72. Broyer M. La nèphrose idlopathique et son traitement [in French). Arch Fr Pediatr 1988: 45: 1-4
73. Elhence R. Gulati S. Kher V. et al. Intravenous pulse cyclophosphamide - a new regime for steroid-resistant minimal change nephrotic syndrome. Pediatr Nephrol 1994: 8: 1-3
74. Ponticelli C. Rizzoni G. Edetbnti A. et al. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 1993: 43: 1377-84
75. Hymes LC. Steroid-resistant, cyclosporin-responsive, relapsing nephrotic syndrome. Pediatr Nephrol 1995; 9: 137-9
76. Mendoza SA. Reznik VM. Griswold WR. et al. Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 1990:4: 303-7
77. Niaudet P. Broyer M. Hahih R. Treatment of nephrotic syndrome with cyclosporin A in children. Clin Nephrol 1991: 35 Suppl. 1: S3I-S36
78. Almeida MP. Almcida HA. Coelho Rosa F. Vincristine in steroid-resistant nephrolic syndrome. Pediatr Nephrol 1994: 8: 79-80
79. McCauley J. Shapiro R. Ellis D. et al. Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 1993: 8: 1286-90
80. West CD. Idiopathic membranoproliferative glomcrulonephritis in childhood. Pediatr Nephrol 1992; 6: 96-103
81. Tarshish P. Bernstein J. Tobin JN, et al. Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone - a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 1992: 6: 123-30
82. Robson AM, Cole BR. Kienstra RA. Severe glomerulonephritis complicated by coagulopathy: treatment with anticoagulant and immunosuppressive drugs. J Pediatr 1977: 90: 881-92
83. Chapman SJ. Cameron JS. Chantier C. Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation. Arch Dis Child 1980: 55: 446-51
84. Garin EH. Williams RL, Fennell RS, et al. Indomethacin in the treatment ot idiopathic minimal lesion nephrotic syndrome. J Pediatr 1978:93: 138-40
85. Pomeran/ A. Wolach B. Bernheim J. et al. Successful treatment of Finnish congenital nephrotic syndrome with captopri! and indomethacin.'j Pediatr 1995; 126: 140-2
86. Akcicek F. Yalniz T. Basci A. et al. Diuretic effect of fruseinide in patients with nephrotic syndrome: is it potentiated by intravenous albumin'.'BMJ 1995:310: 162-3
87. YoshimuraA. IdeuraT. I wasaki S, et al. Aggravation of minimal change nephrotic syndrome by administration of human albumin. Clin Nephrol 1992; 37: 109-14
88. Sakarcan A. Timmons C. Seikaly MG. Reversible idiopathic acute renal failure in children with primary nephrotic syndrome. J Pediatr 1994; 125: 723-7
89. ArneilGC. 164 children with nephrosis. Lancet 1961; ii: 110310
90. Krensky AM. Ingelfinger JR. Grupe WE. Peritonitis in childhood nephrotic syndrome. 1970-1980. Am J Dis Child 1982: 136: 732-6
91. Hover PF. Gonda S. Barthels M. et al. Thromboembolic complications in children with nephrotic syndrome. Acta Paediatr Scand 1986:75: 804-10
92. Mehls O. Andrassy K. Koderisch J. et al. Hemostatisand thromboetnholism in children with nephrotic syndrome: difference from adults. J Pediatr 1987: 110: 862-7
93. André E, Voisin P, André JL, et al. Hemorheological and hemostatic parameters in children with nephrotic syndrome undergoing steroid therapy. Nephron 1994; 68: 184-91
94. Kaysen GA, Gambertoglio J, Felts J, et al. Albumin synthesis, albuminuria and hyperlipemia in nephrotic patients. Kidney Int 1987; 31: 1368-76
95. Joven J, Villabona C, Villela E, et al. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N Engl J Med 1990; 323: 579-84
96. Mattoo TK. Hypothyroidism in infants with nephrotic syndrome. Pediatr Nephrol 1994; 8: 657-9
97. Freundlich M, Bourgoignie JJ, Zilleruelo G, et al. Bone modulating factors in nephrotic children with normal glomerular filtration rate. Pediatrics 1985; 76: 280-5
98. Rees L, Greene SA, Adlard P, et al. Growth and endocrine function in steroid sensitive nephrotic syndrome. Arch Dis Child 1988; 63: 484-90
99. Kaysen GA, Gambertoglio J, Jimenez I, et al. Effect of dietary protein intake on albumin homeostasis in nephrotic patients. Kidney Int 1986; 29: 572-7